CIK 0000109657 · Non-accelerated filer<br>Smaller reporting company
GT Biopharma, Inc.
Sign in to watch- Ticker
- GTBP
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 941620407
- Phone
- (800) 304-9888
- Business address
- 505 MONTGOMERY STREET, 10TH FLOOR, SAN FRANCISCO, CA, 94111
- Former names
- GT Biopharma, Inc., OXIS INTERNATIONAL INC
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $0
- in 0 filings
Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Reading 14 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2010-01-19 | Post Gary M Director | Grant or award | +1,500,000 | $0.23 | $345K | 1,500,000 |
| 2007-11-09 | REPINE JOHN E Director | Grant or award · Non-Qualified Stock Option (right to buy) | +5,000 | 482,187 | ||
| 2007-11-09 | Post Gary M Chief Operating Officer | Grant or award · Non-Qualified Stock Option (right to buy) | +5,000 | 529,583 | ||
| 2007-11-09 | SPOLAR MATTHEW R Director | Grant or award · Non-Qualified Stock Option (right to buy) | +5,000 | 35,000 | ||
| 2007-11-09 | NEILL SYDNEY COLIN Director | Grant or award · Non-Qualified Stock Option (right to buy) | +5,000 | 432,500 | ||
| 2007-01-11 | SPOLAR MATTHEW R Director | Grant or award · Stock Option | +30,000 | 30,000 | ||
| 2006-11-06 | NEILL SYDNEY COLIN Secretary | Grant or award · Common Stock Warrant (right to buy) | +187,500 | 427,500 | ||
| 2006-11-06 | REPINE JOHN E Director | Grant or award | +50,000 | $0.18 | $9K | 50,000 |
| 2006-11-06 | REPINE JOHN E Director | Grant or award · Non-Qualified Stock Option (right to buy) | +200,000 | 277,187 | ||
| 2006-11-06 | REPINE JOHN E Director | Grant or award · Non-Qualified Stock Option (right to buy) | +200,000 | 477,187 | ||
| 2006-11-06 | Post Gary M Director | Grant or award · Common Stock Warrant (right to buy) | +173,608 | 281,608 | ||
| 2006-11-06 | Post Gary M Director | Grant or award · Common Stock Warrant (right to buy) | +550,000 | 831,608 | ||
| 2006-11-06 | Post Gary M Director | Grant or award · Non-Qualified Stock Option (right to buy) | +333,333 | 524,583 | ||
| 2006-11-06 | HAUSMAN MARVIN S MD President & CEO | Grant or award | +347,222 | $0.18 | $62K | 1,834,636 |
| 2006-11-06 | HAUSMAN MARVIN S MD President & CEO | Grant or award | +500,000 | $0.20 | $100K | 2,334,636 |
| 2006-11-06 | HAUSMAN MARVIN S MD President & CEO | Grant or award | +69,444 | $0.18 | $12K | 2,404,080 |
| 2006-11-06 | HAUSMAN MARVIN S MD President & CEO | Grant or award · Non-Qualified Stock Option (right to buy) | +495,000 | 1,209,695 | ||
| 2006-11-06 | HAUSMAN MARVIN S MD President & CEO | Grant or award · Common Stock Warrant (right to buy) | +1,505,000 | 2,714,695 | ||
| 2006-10-12 | Post Gary M Director | Grant or award · Non-Qualified Stock Option (right to buy) | +156,250 | 191,250 | ||
| 2006-10-12 | REPINE JOHN E Director | Grant or award · Non-Qualified Stock Option (right to buy) | +9,787 | 77,187 |
Page 6 of 9 · 164 trades